RTN Therapeutics
Why RTN?
RTN is not an idea. It’s a proven biological tool—refined, revived, and ready.
Originally formulated in 1940s Czechoslovakia, these tissue-based therapies supported thousands of clinical cases in oncology, inflammation, and regeneration—long before “biotech” was a word. Today, we bring them back, not as nostalgia, but as high-precision, nature-based solutions with decades of evidence behind them.
Why Now?
Until ultra-modern science actually works outside the lab, RTN is the closest thing to tomorrow—today.
Validated. Mature. Already Working.
We're not in beta. We're not in theory.
These compounds have been tested in more than 12,000 hospital cases.
“Today, we refine, validate, and reintroduce them as nutraceuticals—under modern safety and regulatory standards for dietary supplements.”
Current Formulations
Retisin
Nucleotide complex rich in AMP, GMP, CMP—delivers metabolic energy where it counts. Think post-radiation recovery, immune collapse, or metabolic fatigue. ATP, on demand.
Lyastin
A phospholipid booster. Supports microcirculation, nerve regeneration, and intercellular signaling. Born at the edge of frostbite and ischemia—now rewriting the rules of recovery.
Floristen
Water-soluble extract of St. John’s Wort, purified for anti-inflammatory and antioxidant properties. Applications in gynecology, inflammation, and systemic oxidative stress.
Silexil
Marine-born. Targeting pain, inflammation, and joint vitality. Being rewritten for the next generation.
The RTN Way: Science With a Spine
All current formulations are undergoing controlled preclinical validation aligned with EU and international dietary supplement safety standards.
Preclinical Trials
Running now. EU-standard. Real data, not declarations.
Open Monitoring
From field to flask: sensors, blockchain, and total transparency.
Biomarker-Based Personalization
CRP? IL-4? Lipid profile? We don’t guess—we match.
Human AI
Our AI helps clinicians decode biomarker chaos. It doesn’t replace them. This isn’t magic. It’s method.
Strategic Track
Clinical Partners
Already in motion: hospitals, labs, researchers across disciplines.
Regulatory Recognition
From historical compound to approved API. Full compliance path, documented.
Publication Pipeline
Data to journals, not just pitch decks.
Be Part of the Revival
We're enrolling volunteers for our groundbreaking longevity and immune resilience observational study.
Join the Study
Tested on data. Customized for you.
Kits (Retisin + Floristen)
Built from your profile. Tracked.
Preferential Pricing
Because early adopters deserve early access.
Biomarker Analysis
No fluff. Just your biology, clearly mapped.
Manufacturing
Production and testing are carried out in a certified eco-farm and state-authorized manufacturing facility. All processes are documented, controlled, and compliant with EU food and nutraceutical production standards.
Legacy With a Backbone
RTN isn’t an experiment. It’s a comeback.
Until molecules are programmable and synthetic life is real—we are the best there is.
Download our whitepaper or contact us directly to explore partnership opportunities.
Join us in reInventedImmunology and see yourself.
Legal Information
Company Registration
RTN Therapeutics s.r.o. | ID: 17380723
Řetouň 66, 400 02 Malečov, Czech Republic
Registered with Regional Court in Ústí nad Labem, File No. C 49191
Trademarks
RTN®, Retisin®, Lyastin®, Floristen®, and Silexil® are registered trademarks of EkoRTN s.r.o.
Licensing
RTN Therapeutics holds exclusive license for production and distribution of all RTN program outcomes.
© 2022–2025. All rights reserved. All other trademarks mentioned are property of their respective owners.